Upper gastrointestinal metastasis of endometrial carcinoma rarely occurs in the absence of locoregional disease and other distant metastases. We describe herein the unique case of an isolated gastric metastasis of a stage I endometrial adenocarcinoma. Because the metastatic tumor was initially misdiagnosed clinically and pathologically as a primary gastric carcinoma, we illustrate the histopathology and review the pertinent literature. A 42-year-old woman with Lynch syndrome underwent treatment of endometrial adenocarcinoma at an outside hospital comprising clinical and radiological staging including a positron emission tomography-computed tomography (PET-CT) scan followed by a total intra-abdominal hysterectomy, bilateral salpingoophorectomy and pelvic and paraaortic lymphadenectomy. The preoperative and pathology findings were consistent with a stage I tumor. Three months postoperatively, a PET-CT scan revealed a new 4.4 cm hypermetabolic lesion in the stomach. A biopsy of the lesion was interpreted pathologically as gastric adenocarcinoma with lymphoid stroma. Upon referral of the patient to our center for management, the biopsy was reviewed in consultation and the pathology materials from the hysterectomy procedure were retrieved for comparison. Based on the morphological and immunohistochemical similarities between the tumors the gastric tumor was diagnosed as metastatic endometrial adenocarcinoma. To our knowledge, this is the first documented case of an isolated gastric metastasis complicating stage I endometrial adenocarcinoma. Awareness of the potential for this occurrence and of the associated diagnostic pitfalls is crucial for accurate diagnosis and therapy.
Introduction
Upper gastrointestinal metastasis of endometrial carcinoma rarely occurs in the absence of locoregional disease and other distant metastases. Based on autopsy data, metastatic uterine and cervical tumors of all types account for only 4-5% of secondary gastric tumors, are associated with carcinomatosis, and are rarely diagnosed antemortem [1, 2] . Documented cases in which the gastrointestinal tract was involved by isolated metastases are exceedingly rare. Bosscher et al reported a case of endometrial carcinoma that metastasized to the small intestine [3] . Another study published in abstract form reported one case of endometrial carcinoma among 38 patients (3%) with metastatic tumors involving the upper gastrointestinal tract during a 17-year interval [4] . The complete clinical scenario is unavailable. We describe herein the unique case of an isolated gastric metastasis of a stage I endometrial adenocarcinoma. To our knowledge the only previous report of isolated gastric metastasis from the endometrium did not provide sufficient morphological or immunohistochemical documentation to exclude an alternative primary site [5] .
Case Report
A 42-year-old woman with a family history of Lynch syndrome presented with menorrhea. She was diagnosed with stage I endometrial adenocarcinoma based on clinical and radiological evaluation which included a positron emission tomography-computed tomography (PET-CT) examination. A hysterectomy was performed which contained a FIGO grade 3 endometrioid adenocarcinoma featuring extensive lymphovascular invasion, with depth of invasion 1.1 cm of 2.5 cm myometrium. The accompanying lymph nodes (12 right pelvic, one right para-aortic, eight left pelvic and 10 left para-aortic) were negative for tumor.
Immunohistochemical staining for DNA mismatch repair proteins of the hysterectomy specimen revealed retained expression of MLH1 and PMS2 accompanied by aberrant cytoplasmic expression and loss of nuclear expression of MSH2 and MSH6 in the tumor cells. Postoperatively, the patient underwent a genetic evaluation which revealed heterozygous MSH2 mutation c1906G>C (p.Ala636pro).
Three months postoperatively, a follow-up PET-CT examination revealed a new 4.4-cm hypermetabolic lesion in the gastric wall with mucosal and mural involvement. No other lesions were detected. An endoscopic biopsy of the gastric lesion was performed and diagnosed as "undifferentiated malignant neoplasm most consistent with gastric carcinoma with lymphoid stroma (lymphoepithelial-like carcinoma/medullary carcinoma)". An endoscopic ultrasound examination was consistent with uT3N1Mx gastric carcinoma.
The patient was referred to our oncology service and her biopsy slides were reviewed in consultation. Based on the referral diagnosis of gastric carcinoma, the plan was to administer neoadjuvant chemotherapy followed by surgical resection of the gastric lesion.
As shown in Figure 1a , H&E-stained sections of the gastric lesion revealed a poorly differentiated carcinoma characterized by dyscohesive tumor cells with a solid growth pattern, prominent necrosis, high nuclear-to-cytoplasmic ratios, large, round to oval nuclei, prominent nucleoli, frequent mitoses and variable amounts of cytoplasm. No obvious gland formation was identified. Scattered intratumoral lymphocytes were noted and confirmed by immunohistochemical staining for leukocyte common antigen (LCA). Referred immunohistochemical stains of the tumor cells were focally positive for AE1/3, diffusely positive for CAM-2 (Fig. 1b) and negative for S100, LCA and CDX-2 (Fig. 1c) . Additional immunohistochemical stains performed in our laboratory were diffusely positive for PAX-8 ( Fig. 1d) and focally positive for estrogen and progesterone receptor proteins. Because of doubts regarding the referral diagnosis, the biopsy slides were compared with slides from the hysterectomy specimen. This disclosed a moderately differentiated endometrioid adenocarcinoma accompanied by a portion of poorly differentiated carcinoma with tumor necrosis and extensive lymphovascular invasion (Fig. 2) . Based on the morphological similarity of the latter component to the biopsy tissue and the immunohistochemical findings, the gastric neoplasm was diagnosed as metastatic endometrial carcinoma.
The patient underwent chemotherapy with 5-fluorourcil, leucovorin, oxaliplatin and docetaxel (FLOT) starting 1 month after the biopsy. A partial gastrectomy performed 2 months later showed no residual carcinoma.
Discussion
Gastric carcinoma with lymphoid stroma, also referred to as medullary carcinoma and lymphoepithelioma-like carcinoma, is a rare entity that was first reported in 1976 [6] . It is characterized microscopically by pushing tumor borders, cohesive tumor cells with a syncytial growth pattern, indistinct tumor cell borders, intratumoral lymphocytes and non-desmoplastic peritumoral stroma containing abundant lymphocytes and plasma cells, and either microsatellite instability or evidence of intratumoral Epstein-Barr virus antigens [7] [8] [9] .
Lynch syndrome patients are at increased risk of developing gastric carcinoma. One study has reported a standardized incidence ratio of 3.4 and mean age of diagnosis of 56 years [10] . These cancers are more commonly intestinal type than diffuse type [11, 12] . There is little data regarding the prevalence of medullary carcinoma of stomach in patients with Lynch syndrome, presumably due to its rarity. In a recently published study, three of five patients with gastric medullary carcinoma were determined to have Lynch Syndrome [8] .
In our case the diagnosis of carcinoma with lymphoid stroma was questioned on the basis of the dyscohesiveness of the tumor cells and sparse intratumoral mononuclear cells with no prominent lymphocytes and plasma cells infiltrates which did not meet the required diagnostic criteria.
The diagnosis of metastatic endometrial carcinoma was suggested by immunohistochemical tumor expression of PAX-8. PAX-8 is a transcriptional factor for organogenesis of Mul- and its absence in six of six gastric cancers (100%) [13] . Another study of 1,357 tumors from various organs reported PAX-8 expression in 152 of 155 endometrial carcinomas (98%) and its absence in 32 of 32 gastric carcinomas (100%) [14] .
Conclusions
To our knowledge, this is the first documented case of an isolated gastric metastasis from endometrial adenocarcinoma and is all the more unusual in that the primary tumor was clinically and pathologically stage I. Awareness of this potential occurrence and the associated diagnostic pitfalls is crucial for accurate diagnosis and therapy.
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